Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
cardiovascular (63) 63
humans (45) 45
index medicus (43) 43
cardiac & cardiovascular systems (36) 36
male (36) 36
female (35) 35
middle aged (34) 34
cardiology and cardiovascular medicine (30) 30
internal medicine (30) 30
heart attacks (26) 26
stents (26) 26
treatment outcome (25) 25
abridged index medicus (24) 24
stent (24) 24
drug-eluting stents (23) 23
aged (21) 21
medical colleges (20) 20
cardiology (19) 19
transluminal angioplasty (18) 18
coronary angiography (17) 17
prospective studies (17) 17
percutaneous coronary intervention (16) 16
time factors (15) 15
analysis (14) 14
cardiovascular disease (13) 13
clinical trials (13) 13
coronary heart disease (12) 12
coronary vessels (12) 12
drug therapy (12) 12
follow-up studies (12) 12
studies (12) 12
clinical outcomes (11) 11
registries (10) 10
thrombosis (10) 10
drug-eluting stent (9) 9
medical education (9) 9
outcomes (9) 9
patients (9) 9
pharmacology & pharmacy (9) 9
republic of korea (9) 9
risk factors (9) 9
angioplasty (8) 8
coronary artery disease - therapy (8) 8
efficacy (8) 8
fractional flow reserve (8) 8
implantation (8) 8
mortality (8) 8
revascularization (8) 8
safety (8) 8
cardiac patients (7) 7
coronary artery disease - mortality (7) 7
coronary disease (7) 7
intervention (7) 7
myocardial infarction - etiology (7) 7
republic of korea - epidemiology (7) 7
retrospective studies (7) 7
adult (6) 6
comparative analysis (6) 6
diabetes (6) 6
disease (6) 6
everolimus (6) 6
follow-up (6) 6
myocardial-infarction (6) 6
percutaneous coronary intervention - methods (6) 6
prognosis (6) 6
severity of illness index (6) 6
sirolimus - analogs & derivatives (6) 6
stent thrombosis (6) 6
therapy (6) 6
ticlopidine - analogs & derivatives (6) 6
women (6) 6
acute coronary syndromes (5) 5
aged, 80 and over (5) 5
angiogenesis inhibitors (5) 5
aspirin (5) 5
care and treatment (5) 5
clopidogrel (5) 5
coronary artery bypass (5) 5
coronary artery disease - diagnostic imaging (5) 5
electrocardiography (5) 5
hypertension (5) 5
medical research (5) 5
meta-analysis (5) 5
myocardial infarction (5) 5
paclitaxel (5) 5
platelet aggregation inhibitors - administration & dosage (5) 5
platelet aggregation inhibitors - adverse effects (5) 5
randomized controlled trials as topic (5) 5
risk assessment (5) 5
stenosis (5) 5
survival rate - trends (5) 5
therapeutic equivalency (5) 5
trial (5) 5
age (4) 4
angiography (4) 4
anticoagulants (4) 4
atherosclerosis (4) 4
bleeding (4) 4
cholesterol (4) 4
coronary stenosis - diagnostic imaging (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Reply
by Jo, Sang-Ho, MD and Koo, Bon-Kwon, MD, PhD and Youn, Tae-Jin, MD, PhD and Kim, Hyo-Soo, MD, PhD
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2007, Volume 49, Issue 15, pp. 1669 - 1670
Cardiovascular | Internal Medicine
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Efficacy and Safety of Dual Antiplatelet Therapy After Complex PCI
by Giustino, Gennaro, MD and Chieffo, Alaide, MD and Palmerini, Tullio, MD and Valgimigli, Marco, MD, PhD and Feres, Fausto, MD and Abizaid, Alexandre, MD and Costa, Ricardo A., MD and Hong, Myeong-Ki, MD, PhD and Kim, Byeong-Keuk, MD, PhD and Jang, Yangsoo, MD, PhD and Kim, Hyo-Soo, MD, PhD and Park, Kyung Woo, MD and Gilard, Martine, MD and Morice, Marie-Claude, MD and Sawaya, Fadi, MD and Sardella, Gennaro, MD and Genereux, Philippe, MD and Redfors, Bjorn, MD, PhD and Leon, Martin B., MD and Bhatt, Deepak L., MD, MPH and Stone, Gregg W., MD and Colombo, Antonio, MD
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2016, Volume 68, Issue 17, pp. 1851 - 1864
Abstract Background Optimal upfront dual antiplatelet therapy (DAPT) duration after complex percutaneous coronary intervention (PCI) with drug-eluting stents... 
Cardiovascular | Internal Medicine | bleeding | drug-eluting stents | stent thrombosis | myocardial infarction | CARDIAC & CARDIOVASCULAR SYSTEMS | THROMBOSIS | LENGTH | RISK | OUTCOMES | ELUTING STENT IMPLANTATION | DURATION | Drug-Eluting Stents | Humans | Middle Aged | Postoperative Complications - prevention & control | Male | Treatment Outcome | Postoperative Complications - epidemiology | Ticlopidine - analogs & derivatives | Aspirin - administration & dosage | Randomized Controlled Trials as Topic | Time Factors | Aspirin - adverse effects | Percutaneous Coronary Intervention - methods | Platelet Aggregation Inhibitors - administration & dosage | Ticlopidine - adverse effects | Ticlopidine - administration & dosage | Female | Drug Therapy, Combination | Postoperative Complications - chemically induced | Platelet Aggregation Inhibitors - adverse effects | Transluminal angioplasty | Medical colleges | Continuing medical education | Cardiac patients | Medical care | Research institutes | Cardiology | Quality management | Studies | Short term | Heart attacks | Mortality | Clinical trials | Cardiovascular disease | Diabetes | Stents | Thrombosis | Patients | Data bases
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Predictors and Outcomes of Side Branch Occlusion After Main Vessel Stenting in Coronary Bifurcation Lesions
by Hahn, Joo-Yong, MD, PhD and Chun, Woo Jung, MD, PhD and Kim, Ji-Hwan, MD and Song, Young Bin, MD, PhD and Oh, Ju Hyeon, MD, PhD and Koo, Bon-Kwon, MD, PhD and Rha, Seung Woon, MD, PhD and Yu, Cheol Woong, MD, PhD and Park, Jong-Sun, MD, PhD and Jeong, Jin-Ok, MD, PhD and Choi, Seung-Hyuk, MD, PhD and Choi, Jin-Ho, MD, PhD and Jeong, Myung-Ho, MD, PhD and Yoon, Jung Han, MD, PhD and Jang, Yangsoo, MD, PhD and Tahk, Seung-Jea, MD, PhD and Kim, Hyo-Soo, MD, PhD and Gwon, Hyeon-Cheol, MD, PhD
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2013, Volume 62, Issue 18, pp. 1654 - 1659
Objectives This study sought to investigate the predictors and outcomes of side branch (SB) occlusion after main vessel (MV) stenting in coronary bifurcation... 
Cardiovascular | Internal Medicine | angioplasty | bifurcation lesion | side branch | IMPACT | CARDIAC & CARDIOVASCULAR SYSTEMS | IMPLANTATION | ANGIOGRAPHIC PREDICTORS | REAL-WORLD PRACTICE | INTRAVASCULAR ULTRASOUND | INTERVENTION | REGISTRY | Sects | Medical colleges | Stent (Surgery) | Studies | Heart attacks | Angioplasty | Stents | Clinical outcomes
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Response to the letter to the Editor
by Kang, Hyun-Jae, MD, PhD and Kim, Hyo-Soo, MD, PhD
American Heart Journal, ISSN 0002-8703, 2007, Volume 154, Issue 2, pp. e19 - e19
  [...]our patients received dual antiplatelet agents and anticoagulant to stabilize their condition and reduce potential risk of thromboembolism. [...]we have... 
Cardiovascular | Clinical trials | Heart attacks | Blood diseases | Drug therapy | Editors
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Bleeding-Related Deaths in Relation to the Duration of Dual-Antiplatelet Therapy After Coronary Stenting
by Palmerini, Tullio, MD and Bacchi Reggiani, Letizia, MStat and Della Riva, Diego, MD and Romanello, Mattia, MD and Feres, Fausto, MD and Abizaid, Alexandre, MD and Gilard, Martine, MD and Morice, Marie-Claude, MD and Valgimigli, Marco, MD, PhD and Hong, Myeong-Ki, MD, PhD and Kim, Byeong-Keuk, MD, PhD and Jang, Yangsoo, MD, PhD and Kim, Hyo-Soo, MD, PhD and Park, Kyung Woo, MD and Colombo, Antonio, MD and Chieffo, Alaide, MD and Ahn, Jung-Min, MD and Park, Seung-Jung, MD and Schüpke, Stefanie, MD and Kastrati, Adnan, MD and Montalescot, Gilles, MD and Steg, Philippe Gabriel, MD and Diallo, Abdourahmane, MD and Vicaut, Eric, MD and Helft, Gerard, MD and Biondi-Zoccai, Giuseppe, MD, MStat and Xu, Bo, MD and Han, Yaling, MD and Genereux, Philippe, MD and Bhatt, Deepak L., MD, MPH and Stone, Gregg W., MD
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2017, Volume 69, Issue 16, pp. 2011 - 2022
Abstract Background Although some randomized controlled trials (RCTs) and meta-analyses have suggested that prolonged dual-antiplatelet therapy (DAPT) may be... 
Cardiovascular | Internal Medicine | mortality | drug-eluting stent | dual antiplatelet therapy | CARDIAC & CARDIOVASCULAR SYSTEMS | METAANALYSIS | EVENTS | MYOCARDIAL-INFARCTION | EFFICACY | LONG-TERM MORTALITY | PAIRWISE | dual antiplatelet therapy | TRIAL | ELUTING STENTS | IMPLANTATION | ASSOCIATION | Drug-Eluting Stents | Humans | Platelet Aggregation Inhibitors - administration & dosage | Hemorrhage - mortality | Hemorrhage - chemically induced | Postoperative Complications - mortality | Postoperative Complications - chemically induced | Percutaneous Coronary Intervention | Platelet Aggregation Inhibitors - adverse effects | Randomized Controlled Trials as Topic | Medical colleges | Analysis | Mortality | Research institutes | Cardiology | Heart diseases | Stent (Surgery) | Therapy | Surgical implants | Heart attacks | Meetings | Clinical trials | Implantation | Drug delivery | Multivariate analysis | Patients | Bleeding | Meta-analysis | Confidence intervals | Studies | Motivation | Collaboration | Implants | Health hazards | Fatalities | Secondary analysis | Acute coronary syndromes | Stents
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Optimal Intravascular Ultrasound Criteria and Their Accuracy for Defining the Functional Significance of Intermediate Coronary Stenoses of Different Locations
by Koo, Bon-Kwon, MD, PhD and Yang, Hyoung-Mo, MD and Doh, Jun-Hyung, MD, PhD and Choe, Hyunmin, MD and Lee, Sung-Yun, MD, PhD and Yoon, Chang-Hwan, MD, PhD and Cho, Yun-Kyeong, MD, PhD and Nam, Chang-Wook, MD, PhD and Hur, Seung-Ho, MD, PhD and Lim, Hong-Seok, MD, PhD and Yoon, Myeong-Ho, PhD and Park, Kyung-Woo, MD, PhD and Na, Sang-Hoon, MD, PhD and Youn, Tae-Jin, MD, PhD and Chung, Woo-Young, MD, PhD and Ma, Seunghyun, MD and Park, Sue-Kyung, MD, PhD and Kim, Hyo-Soo, MD, PhD and Tahk, Seung-Jea, MD, PhD
JACC: Cardiovascular Interventions, ISSN 1936-8798, 2011, Volume 4, Issue 7, pp. 803 - 811
Objectives We performed this study to determine the optimal intravascular ultrasound (IVUS) criteria and to evaluate their accuracy for defining the functional... 
Cardiovascular | physiology | coronary disease | intravascular ultrasound | stenosis | fractional flow reserve | ARTERY STENOSES | CONTINUOUS ADENOSINE INFUSION | CARDIAC & CARDIOVASCULAR SYSTEMS | INTRAVENOUS ADENOSINE | ANGIOGRAPHY | INTRACORONARY | DISEASE | INTERVENTION | SEVERITY | MAXIMAL HYPEREMIA | Coronary Stenosis - diagnostic imaging | Coronary Vessels - diagnostic imaging | Severity of Illness Index | Reproducibility of Results | Prognosis | Prospective Studies | Coronary Circulation - physiology | Follow-Up Studies | Coronary Vessels - physiopathology | Humans | Middle Aged | Male | Vascular Resistance - physiology | Ultrasonography, Interventional - standards | Coronary Angiography | Coronary Stenosis - physiopathology | Female
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Pre-Treatment of Mesenchymal Stem Cells With a Combination of Growth Factors Enhances Gap Junction Formation, Cytoprotective Effect on Cardiomyocytes, and Therapeutic Efficacy for Myocardial Infarction
by Hahn, Joo-Yong, MD, PhD and Cho, Hyun-Ju, MS and Kang, Hyun-Jae, MD, PhD and Kim, Tack-Seung, MS and Kim, Mi-Hyung, PhD and Chung, Jung-Hwa, MD and Bae, Jang-Whan, MD, PhD and Oh, Byung-Hee, MD, PhD and Park, Young-Bae, MD, PhD and Kim, Hyo-Soo, MD, PhD
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2008, Volume 51, Issue 9, pp. 933 - 943
Pre-Treatment of Mesenchymal Stem Cells With a Combination of Growth Factors Enhances Gap Junction Formation, Cytoprotective Effect on Cardiomyocytes, and... 
Cardiovascular | Internal Medicine | CONNEXIN43 EXPRESSION | SURVIVAL | CARDIAC FIBROBLASTS | IN-VITRO | CARDIAC & CARDIOVASCULAR SYSTEMS | INTERCELLULAR COMMUNICATION | ISCHEMIC-HEART | DIFFERENTIATION | MODEL | TRANSPLANTATION | BETA | Gap Junctions - metabolism | Mesenchymal Stromal Cells - drug effects | Gene Expression | Insulin-Like Growth Factor I - pharmacology | Bone Morphogenetic Protein 2 | Rats, Inbred F344 | Fibroblast Growth Factor 2 - pharmacology | Rats | Male | Myocardial Infarction - therapy | Transforming Growth Factor beta - pharmacology | Animals | Myocytes, Cardiac - drug effects | Cell Differentiation - drug effects | Myocytes, Cardiac - metabolism | Gap Junctions - drug effects | Bone Morphogenetic Proteins - pharmacology | Mesenchymal Stem Cell Transplantation | Disease Models, Animal | Stem cell research | Stem cells | Heart cells | Bone morphogenetic proteins | Fibroblast growth factors | Health aspects | Heart attack | Medical colleges | Care and treatment | Transplantation | Research institutes | Biotechnology | Rodents | Bone marrow | Cardiomyocytes | Insulin-like growth factors | Laboratory animals | Experiments
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Impact of intravascular ultrasound guidance on long-term clinical outcomes in patients treated with drug-eluting stent for bifurcation lesions: Data from a Korean multicenter bifurcation registry
by Kim, Jung-Sun, MD, PhD and Hong, Myeong-Ki, MD, PhD and Ko, Young-Guk, MD, PhD and Choi, Donghoon, MD, PhD and Yoon, Jung Han, MD, PhD and Choi, Seung-Hyuk, MD, PhD and Hahn, Joo-Yong, MD, PhD and Gwon, Hyeon-Cheol, MD, PhD and Jeong, Myung-Ho, MD, PhD and Kim, Hyo-Soo, MD, PhD and Seong, In-Whan, MD, PhD and Yang, Joo-Young, MD, PhD and Rha, Seung Woon, MD, PhD and Tahk, Seung-Jea, MD, PhD and Seung, Ki Bae, MD, PhD and Park, Seung-Jung, MD, PhD and Jang, Yangsoo, MD, PhD
American Heart Journal, ISSN 0002-8703, 2011, Volume 161, Issue 1, pp. 180 - 187
Background Although intravascular ultrasound (IVUS) has been widely used for complex lesions during coronary intervention, IVUS for stenting at bifurcation... 
Cardiovascular | ANGIOGRAPHIC GUIDANCE | CARDIAC & CARDIOVASCULAR SYSTEMS | CORONARY | IMPLANTATION | THROMBOSIS | MAIN | INTERVENTION | Coronary Stenosis - diagnostic imaging | Ultrasonography, Interventional - methods | Drug-Eluting Stents | Reproducibility of Results | Prognosis | Survival Rate - trends | Follow-Up Studies | Humans | Middle Aged | Male | Treatment Outcome | Coronary Stenosis - surgery | Time Factors | Female | Coronary Stenosis - mortality | Retrospective Studies | Korea - epidemiology | Stent (Surgery) | Heart attacks | Angioplasty | Stents | Clinical outcomes
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Safety and efficacy of everolimus- versus sirolimus-eluting stents: A systematic review and meta-analysis of 11 randomized trials
by Park, Kyung Woo, MD, PhD and Kang, Si-Hyuck, MD and Velders, Matthijs A., MD and Shin, Dong-Ho, MD and Hahn, Seokyung, PhD and Lim, Woo-Hyun, MD and Yang, Han-Mo, MD, PhD and Lee, Hae-Young, MD, PhD and Van Boven, Adrianus J., MD, PhD and Hofma, Sjoerd H., MD, PhD and Kang, Hyun-Jae, MD, PhD and Koo, Bon-Kwon, MD, PhD and Oh, Byung-Hee, MD, PhD and Park, Young-Bae, MD, PhD and Kandzari, David E., MD and Kim, Hyo-Soo, MD, PhD
American Heart Journal, ISSN 0002-8703, 2013, Volume 165, Issue 2, pp. 241 - 250.e4
Background While EES have proven superior to paclitaxel-eluting stents, it remains uncertain whether EES improve clinical outcomes compared to SES, which are... 
Cardiovascular | CARDIAC & CARDIOVASCULAR SYSTEMS | XIENCE/PROMUS | POLYMER | CYPHER | INTERVENTION | CORONARY-ARTERY-DISEASE | LESIONS | Drug-Eluting Stents | Sirolimus - analogs & derivatives | Coronary Artery Disease - therapy | Humans | Antineoplastic Agents | Treatment Outcome | Everolimus | Immunosuppressive Agents - pharmacology | Sirolimus - pharmacology | Randomized Controlled Trials as Topic | Analysis | Cardiac patients | Stent (Surgery) | Studies | Heart attacks | Drug therapy | Cardiology | Stents
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Clinical Outcomes Following Transcatheter Aortic Valve Replacement in Asian Population
by Yoon, Sung-Han, MD and Ahn, Jung-Min, MD and Hayashida, Kentaro, MD, PhD and Watanabe, Yusuke, MD, PhD and Shirai, Shinichi, MD and Kao, Hsien-Li, MD and Yin, Wei-Hsian, MD and Lee, Michael Kang-yin, MD and Tay, Edgar, MD and Araki, Motoharu, MD and Yamanaka, Futoshi, MD and Arai, Takahide, MD and Lin, Mao-Shin, MD and Park, Jun-Bean, MD and Park, Duk-Woo, MD, PhD and Kang, Soo-Jin, MD, PhD and Lee, Seung-Whan, MD, PhD and Kim, Young-Hak, MD, PhD and Lee, Cheol Whan, MD, PhD and Park, Seong-Wook, MD, PhD and Muramatsu, Toshiya, MD and Hanyu, Michiya, MD, PhD and Kozuma, Ken, MD and Kim, Hyo-Soo, MD, PhD and Saito, Shigeru, MD and Park, Seung-Jung, MD, PhD and Asian TAVR Investigators
JACC: Cardiovascular Interventions, ISSN 1936-8798, 2016, Volume 9, Issue 9, pp. 926 - 933
Abstract Objectives This study describes the characteristics of a real-world Asian patient population treated with transcatheter aortic valve replacement... 
Cardiovascular | transcatheter aortic valve replacement | Asia | aortic stenosis | Multivariate Analysis | Prospective Studies | Humans | Male | Aortic Valve Stenosis - ethnology | Prosthesis Design | Aortic Valve Stenosis - diagnostic imaging | Aortic Valve Stenosis - mortality | Time Factors | Aged, 80 and over | Female | Registries | Aortic Valve Stenosis - surgery | Transcatheter Aortic Valve Replacement - adverse effects | Transcatheter Aortic Valve Replacement - instrumentation | Risk Assessment | Heart Valve Prosthesis | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Treatment Outcome | Chi-Square Distribution | Asia - epidemiology | Asian Continental Ancestry Group | Postoperative Complications - ethnology | Aged | Transcatheter Aortic Valve Replacement - mortality
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Everolimus-Eluting Xience V/Promus Versus Zotarolimus-Eluting Resolute Stents in Patients With Diabetes Mellitus
by Park, Kyung Woo, MD, PhD and Lee, Joo Myung, MD, MPH and Kang, Si-Hyuck, MD and Ahn, Hyo-Suk, MD and Kang, Hyun-Jae, MD, PhD and Koo, Bon-Kwon, MD, PhD and Rhew, Jay Young, MD, PhD and Hwang, Sun Ho, MD, PhD and Lee, Sung Yoon, MD, PhD and Kang, Tae Soo, MD, PhD and Kwak, Choong Hwan, MD, PhD and Hong, Bum-Kee, MD, PhD and Yu, Cheol Woong, MD, PhD and Seong, In-Whan, MD, PhD and Ahn, Taehoon, MD, PhD and Lee, Han Cheol, MD, PhD and Lim, Sang Wook, MD, PhD and Kim, Hyo-Soo, MD, PhD
JACC: Cardiovascular Interventions, ISSN 1936-8798, 2014, Volume 7, Issue 5, pp. 471 - 481
Objectives This study sought to compare everolimus-eluting stents (EES) versus Resolute zotarolimus-eluting stents (ZES) in terms of patient- or stent-related... 
Cardiovascular | everolimus | percutaneous coronary intervention | zotarolimus | diabetes mellitus | drug-eluting stent | DEFINITIONS | PERCUTANEOUS CORONARY INTERVENTION | REVASCULARIZATION | CARDIAC & CARDIOVASCULAR SYSTEMS | IMPLANTATION | TWENTE TRIAL | BARE-METAL | REAL-WORLD PATIENTS | OUTCOMES | V STENTS | ELEVATION MYOCARDIAL-INFARCTION | Multivariate Analysis | Myocardial Infarction - mortality | Humans | Middle Aged | Diabetic Angiopathies - etiology | Male | Diabetes Mellitus, Type 1 - complications | Prosthesis Design | Patient Selection | Percutaneous Coronary Intervention - instrumentation | Time Factors | Female | Registries | Everolimus | Myocardial Infarction - etiology | Diabetes Mellitus, Type 2 - complications | Republic of Korea | Cardiovascular Agents - administration & dosage | Drug-Eluting Stents | Sirolimus - analogs & derivatives | Coronary Artery Disease - etiology | Risk Factors | Diabetic Angiopathies - mortality | Kaplan-Meier Estimate | Proportional Hazards Models | Logistic Models | Treatment Outcome | Coronary Artery Disease - mortality | Chi-Square Distribution | Diabetes Mellitus, Type 1 - mortality | Diabetic Angiopathies - therapy | Coronary Angiography | Diabetes Mellitus, Type 1 - diagnosis | Diabetes Mellitus, Type 2 - diagnosis | Propensity Score | Sirolimus - administration & dosage | Coronary Artery Disease - therapy | Coronary Artery Disease - diagnosis | Diabetes Mellitus, Type 2 - mortality | Kidney Failure, Chronic - complications | Diabetic Angiopathies - diagnosis | Aged | Percutaneous Coronary Intervention - adverse effects
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Clinical and Physiological Outcomes of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention in Patients With Serial Stenoses Within One Coronary Artery
by Kim, Hack-Lyoung, MD and Koo, Bon-Kwon, MD, PhD and Nam, Chang-Wook, MD, PhD and Doh, Joon-Hyung, MD, PhD and Kim, Ji-Hyun, MD and Yang, Han-Mo, MD, PhD and Park, Kyung-Woo, MD, PhD and Lee, Hae-Young, MD, PhD and Kang, Hyun-Jae, MD, PhD and Cho, Young-Seok, MD, PhD and Youn, Tae-Jin, MD, PhD and Kim, Sang-Hyun, MD, PhD and Chae, In-Ho, MD, PhD and Choi, Dong-Ju, MD, PhD and Kim, Hyo-Soo, MD, PhD and Oh, Byung-Hee, MD, PhD and Park, Young-Bae, MD, PhD
JACC: Cardiovascular Interventions, ISSN 1936-8798, 2012, Volume 5, Issue 10, pp. 1013 - 1018
Objectives This study was performed to evaluate the physiological and clinical outcomes of fractional flow reserve (FFR)-guided revascularization strategy with... 
Cardiovascular | physiology | coronary disease | stenosis | fractional flow reserve | ANGIOGRAPHY | CARDIAC & CARDIOVASCULAR SYSTEMS | CARDIOLOGY | PRESSURE MEASUREMENT | INTRAVASCULAR ULTRASOUND | Coronary Vessels - pathology | Drug-Eluting Stents | Prognosis | Humans | Middle Aged | Coronary Restenosis - prevention & control | Male | Treatment Outcome | Statistics as Topic | Coronary Restenosis - therapy | Angioplasty, Balloon, Coronary | Coronary Angiography | Coronary Artery Disease - therapy | Fractional Flow Reserve, Myocardial | Female | Hemodynamics | Republic of Korea
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Impact of Clinical Presentation (Stable Angina Pectoris vs Unstable Angina Pectoris or Non–ST-Elevation Myocardial Infarction vs ST-Elevation Myocardial Infarction) on Long-Term Outcomes in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents
by Giustino, Gennaro, MD and Baber, Usman, MD, MSc and Stefanini, Giulio Giuseppe, MD and Aquino, Melissa, MSc and Stone, Gregg W., MD and Sartori, Samantha, PhD and Steg, Philippe Gabriel, MD and Wijns, William, MD, PhD and Smits, Pieter C., MD, PhD and Jeger, Raban V., MD and Leon, Martin B., MD and Windecker, Stephan, MD, PhD and Serruys, Patrick W., MD, PhD and Morice, Marie-Claude, MD and Camenzind, Edoardo, MD and Weisz, Giora, MD and Kandzari, David, MD and Dangas, George D., MD, PhD and Mastoris, Ioannis, MD and Von Birgelen, Clemens, MD, PhD and Galatius, Soren, MD, PhD and Kimura, Takeshi, MD, PhD and Mikhail, Ghada, MD and Itchhaporia, Dipti, MD and Mehta, Laxmi, MD and Ortega, Rebecca, MD and Kim, Hyo-Soo, MD, PhD and Valgimigli, Marco, MD, PhD and Kastrati, Adnan, MD and Chieffo, Alaide, MD and Mehran, Roxana, MD
American Journal of Cardiology, The, ISSN 0002-9149, 2015, Volume 116, Issue 6, pp. 845 - 852
The long-term risk associated with different coronary artery disease (CAD) presentations in women undergoing percutaneous coronary intervention (PCI) with... 
Cardiovascular | METIS-313896 | IR-98765 | MORTALITY | TRIALS | AMI HARMONIZING OUTCOMES | REVASCULARIZATION | CARDIAC & CARDIOVASCULAR SYSTEMS | CARDIOLOGY | EFFICACY | SAFETY | SEX-DIFFERENCES | LEVEL POOLED ANALYSIS | Myocardial Infarction - surgery | Coronary Artery Disease - surgery | Drug-Eluting Stents | Humans | Middle Aged | Proportional Hazards Models | Treatment Outcome | Angina, Stable - surgery | Coronary Angiography | Coronary Artery Disease - diagnostic imaging | Coronary Artery Disease - complications | Female | Aged | Myocardial Infarction - etiology | Percutaneous Coronary Intervention | Angina, Stable - etiology | Angina, Unstable - etiology | Angina, Unstable - surgery | Women | Transluminal angioplasty | Unstable angina | Mortality | Stent (Surgery) | Heart attack | Heart attacks | Angina pectoris | Cardiology | Stents | Clinical outcomes
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text Three-Year Patient-Related and Stent-Related Outcomes of Second-Generation Everolimus-Eluting Xience V Stents Versus Zotarolimus-Eluting Resolute Stents in Real-World Practice (from the Multicenter Prospective EXCELLENT and RESOLUTE-Korea Registries)
by Lee, Joo Myung, MD, MPH and Park, Kyung Woo, MD, PhD and Han, Jung-Kyu, MD, PhD and Yang, Han-Mo, MD, PhD and Kang, Hyun-Jae, MD, PhD and Koo, Bon-Kwon, MD, PhD and Bae, Jang-Whan, MD, PhD and Woo, Sung-Il, MD, PhD and Park, Jin Sik, MD, PhD and Jin, Dong-Kyu, MD, PhD and Jeon, Dong Woon, MD, PhD and Oh, Seok Kyu, MD, PhD and Park, Jong-Seon, MD, PhD and Kim, Doo-Il, MD, PhD and Hyon, Min Su, MD, PhD and Jeon, Hui-Kyung, MD, PhD and Lim, Do-Sun, MD, PhD and Kim, Myeong-Gon, MD, PhD and Rha, Seung-Woon, MD, PhD and Her, Sung-Ho, MD,PhD and Hwang, Jin-Yong, MD, PhD and Kim, Sanghyun, MD, PhD and Choi, Young Jin, MD, PhD and Kang, Jin Ho, MD, PhD and Moon, Keon-Woong, MD, PhD and Jang, Yangsoo, MD, PhD and Kim, Hyo-Soo, MD, PhD
American Journal of Cardiology, The, ISSN 0002-9149, 2014, Volume 114, Issue 9, pp. 1329 - 1338
Long-term outcomes are imperative to confirm safety of drug-eluting stents. There have been 2 randomized controlled trials comparing everolimus-eluting stents... 
Cardiovascular | DIABETES-MELLITUS | TRIAL | DEFINITIONS | PERCUTANEOUS CORONARY INTERVENTION | REVASCULARIZATION | CARDIAC & CARDIOVASCULAR SYSTEMS | DISEASE | 2-YEAR FOLLOW-UP | Coronary Artery Disease - surgery | Drug-Eluting Stents | Sirolimus - analogs & derivatives | Prospective Studies | Survival Rate - trends | Follow-Up Studies | Humans | Middle Aged | Antineoplastic Agents | Male | Treatment Outcome | Coronary Artery Disease - mortality | Prosthesis Design | Sirolimus - pharmacology | Coronary Angiography | Coronary Artery Disease - diagnostic imaging | Time Factors | Percutaneous Coronary Intervention - methods | Electrocardiography | Female | Registries | Republic of Korea - epidemiology | Everolimus | Immunosuppressive Agents - pharmacology | Analysis | Stent (Surgery) | Angiogenesis inhibitors | Heart attacks | Drug therapy | Stents | Coronary vessels | Clinical outcomes
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Full Text Sex Differences in Management and Mortality of Patients With ST-Elevation Myocardial Infarction (from the Korean Acute Myocardial Infarction National Registry)
by Kang, Si-Hyuck, MD and Suh, Jung-Won, MD, PhD and Yoon, Chang-Hwan, MD, PhD and Cho, Myeong Chan, MD, PhD and Kim, Young Jo, MD, PhD and Chae, Shung Chull, MD, PhD and Yoon, Jung Han, MD, PhD and Gwon, Hyeon-Cheol, MD, PhD and Han, Kyoo-Rok, MD, PhD and Kim, Joo Han, MD, PhD and Ahn, Young-Keun, MD, PhD and Jeong, Myung-Ho, MD, PhD and Kim, Hyo-Soo, MD, PhD and Choi, Dong-Ju, MD, PhD and KAMIR KorMI Registry and KAMIR/KorMI Registry
American Journal of Cardiology, The, ISSN 0002-9149, 2012, Volume 109, Issue 6, pp. 787 - 793
There has been controversy over the disparity between men and women with regard to the management and prognosis of acute myocardial infarction. Analyzing... 
Cardiovascular | HOSPITAL MORTALITY | WOMEN | PERCUTANEOUS CORONARY INTERVENTION | CARDIAC & CARDIOVASCULAR SYSTEMS | PROPENSITY SCORE | MEN | DISEASE | DEATH | OUTCOMES | PRIMARY ANGIOPLASTY | Myocardial Infarction - epidemiology | Survival Rate - trends | Follow-Up Studies | Humans | Middle Aged | Male | Myocardial Infarction - therapy | Sex Factors | Electrocardiography | Sex Distribution | Cause of Death - trends | Female | Registries | Aged | Disease Management | Retrospective Studies | Republic of Korea - epidemiology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights